Modular Medical, Inc. (MODD) Gets Positive ISO 13485 Decision Toward Certification
Modular Medical (MODD) received a positive ISO 13485:2016 decision, a step toward certification. The company aims for a 2027 CE Mark submission for its Pivot tubeless patch pump under EU MDR. This milestone supports its EU launch plan, with certification and CE Mark expected to enable distribution and revenue.
How this was made
The 30-second read
Why it matters
The ISO 13485 decision is a prerequisite for CE Mark, unlocking EU distribution and revenue streams.
Market read
Regulatory clearance could drive near‑term price appreciation for MODD as EU launch becomes feasible.
What to watch
Potential competition from established pump manufacturers and reimbursement uncertainties in Europe.
Background
Modular Medical is targeting a 2027 CE Mark submission for its Pivot tubeless patch pump under EU MDR.
Ticker impact
Modular Medical received a positive notified body decision toward ISO 13485 certification, a key step toward EU CE Mark for its Pivot pump.
potential upside as investors price in EU market entry
Regulatory approval is a material catalyst for a micro‑cap medical device firm.
Market effects
May boost sentiment for EU‑focused med‑tech and device companies awaiting regulatory clearance.
Could positively affect European medical device market sentiment.
Limited to niche med‑tech sector, but highlights regulatory pathways for similar firms.
Counterpoint
If EU approval delays or market uptake is slower than expected, the catalyst could be overstated.
Key entities
- companyModular Medical, Inc.
Medical device maker developing the Pivot pump.
